Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.29
-0.19 (-2.54%)
At close: Sep 25, 2026, 4:00 PM EDT
7.25
-0.04 (-0.55%)
After-hours: Sep 25, 2026, 7:59 PM EDT
Solid Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
121
Market Cap
781.67M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 8.09M | -5.53M | -40.57% |
| Dec 31, 2021 | 13.62M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ardelyx | 450.89M |
| Rigel Pharmaceuticals | 276.79M |
| Theravance Biopharma | 104.31M |
| 4D Molecular Therapeutics | 92.01M |
| Lexicon Pharmaceuticals | 41.47M |
| Inventiva | 7.94M |
| Attovia Therapeutics | 1.80M |
| Avalo Therapeutics | 59.00K |
SLDB News
- 9 days ago - Solid Biosciences initiated with an Outperform at RBC Capital - TheFly
- 11 days ago - Solid Biosciences Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 15 days ago - Solid Biosciences Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 16 days ago - Solid Biosciences management to meet with Cantor - TheFly
- 16 days ago - Solid Biosciences Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 23 days ago - Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Solid Biosciences price target raised to $26 from $16 at Cantor Fitzgerald - TheFly
- 5 weeks ago - Solid Biosciences assumed with a Buy at Truist - TheFly